Skip to main content
Frontiers in Neuroscience logoLink to Frontiers in Neuroscience
. 2012 Jul 26;6:112. doi: 10.3389/fnins.2012.00112

Critical Evaluation of Ayurvedic Plants for Stimulating Intrinsic Antioxidant Response

Sunil Dutt Shukla 1,2, Maheep Bhatnagar 2, Sukant Khurana 3,*
PMCID: PMC3405414  PMID: 22855669

Abstract

Oxidative damage caused by free radicals plays an important role in the causation and progression of many diseases, including aging. Free-radical damage is countered by many mechanisms, including both active antioxidant enzymatic activity in our body and passive antioxidants. Antioxidant response of our body can accommodate increased oxidative damage in diseased states to a level but beyond that level, additional antioxidants are required to combat the increased stress. Apart from the regular dietary sources of antioxidants, many traditional herbal medicines demonstrate a potential to boost antioxidant activity. Rasayana chikitsa that deals with rejuvenation and revitalization is a branch of the Indian traditional medical system of ayurveda. We review some select herbs described in rasayana chikitsa that have been assessed by modern means for stimulating intrinsic antioxidant responses in humans. A critical evaluation of rasayana chikitsa will likely provide urgently needed, actual stimulants of our physiological antioxidant responses and not just more passive antioxidants to add to an already large catalog.

Keywords: antioxidants, central nervous system, reactive oxygen species, traditional medicine, ayurveda, rasayana chikitsa, aging, herbs

Introduction

Oxidative stress arises when the antioxidant defense system of the human body is not entirely efficient. In response to a mild oxidative stress, our body can increase antioxidant defense but severe oxidative stress increases free radicals that can lead to cellular injury and death. Evidence suggests that free radicals, induced due to oxidative stress contribute to aging in general and various diseases, including neurodegenerative diseases, chronic inflammatory diseases, cancer, and cardiovascular disorders (Halliwell, 1994, 2001).

In this review, we will first provide a brief primer on oxidative damage and then focus on ayurvedic plants that have been assessed with contemporary approaches for their antioxidant potential, specifically wherever literature permits, to focus on the stimulation of bodily responses to counteract oxidative damage. The reason for us to focus specifically on stimulation of bodily antioxidant response is because of ambiguous evidence of health benefits of passive antioxidant supplements, while there being a dire need to counteract oxidative damage in many diseases. The purpose of this review is to attract attention of researchers to critically evaluate the potential of the traditional Indian herbal pharmacopeia.

What is Oxidative Stress and How is it Counteracted?

Oxidative stress constitutes an alteration that is encountered when there is an imbalance between the production of reactive oxygen species (ROS) and the ability of the biological system to readily detoxify these reactive intermediates or easily repair the resulting damage. ROS can be a result of environmental insults, like cigaret smoking and ionizing irradiation but majority of ROS are produced in the normal functioning of the body, from intracellular sources (Sastre et al., 2000; Ames, 2004). Sources of one-electron reduction product of molecular oxygen include Fenton reaction, Haber–Weiss reaction, NAD(P)H oxidases (NOX), xanthine oxidase (XO), mieloperoxidase, cytochrome P450, mitochondria, and uncoupled nitric oxide synthase. Additionally peroxynitrite that yields secondary one-electron oxidants has been implicated in cellular damage (Radi et al., 2001).

Free radicals can interact with almost all the bio-molecules in different ways, altering their natural properties and making them more susceptible to damage. Such oxidative damage affects almost all components of the cellular machinery such as carbohydrates, lipids, proteins, and nucleic acids. Both the ROS and the end products of their reaction with various bio-molecules can cause DNA damage by altering its nitrogenous bases (Valko et al., 2004, 2006, 2007). Damage to the mitochondrial DNA, instead of nuclear DNA, is usually a more frequent cause of pathophysiology induced due to oxidative damage. ROS can also directly cause single and double strand breaks in the mitochondrial DNA strands, just as in nuclear DNA (Durham et al., 2006). Close proximity to the sites of ROS generation from the respiratory chain, lack of histone guard, and limited capacity for DNA-damage repair make the mitochondrial DNA 10–100 times more susceptible to oxidative damage as compared to the nuclear DNA (Ames et al., 1993; Floyd and Hensley, 2002).

Lipid peroxidation, is a free-radical mediated feed-forward chain reaction that apart from disrupting cellular membranes, can inactivate the other cellular components. Peroxidation involves the direct reaction of oxygen and lipid to form radical intermediates and semi-stable peroxides that in turn damage the cellular proteins, enzymes, nucleic acids, and membranes (Devasagayam et al., 2003). Malondialdehyde (MDA), which is a major end product of lipid peroxidation is frequently used as an index of the overall lipid peroxidation (Devasagayam et al., 2003). It cross-links proteins with nucleotides, which causes significant cellular damage (Sivalokanathan et al., 2006). The impact of oxidative damage on carbohydrates is relatively less studied. Free radicals such as react •OH with carbohydrates by randomly abstracting a hydrogen atom from one of the carbon atoms, producing a carbon-centered radical. This leads to chain breaks in the carbohydrate molecules (Halliwell, 1994; Stohs, 1995; Griffiths and Lunec, 1996; Devasagayam et al., 2004). High abundance of proteins and their rapid rates of reaction with radicals and excited-state species, including singlet oxygen, make them the most susceptible biological targets for oxidative damage within the cell (Gracanin et al., 2009). Protein oxidation occurs as part of normal regulatory processes, as a defense mechanism against oxidative stress, or as deleterious processes when antioxidant defenses are overcome (Barelli et al., 2008). Although most oxidized proteins that are functionally inactive are rapidly removed, some can gradually accumulate with time and thereby contribute to the damage associated with aging as well as various diseases. Lipofuscin, an aggregate of peroxidized lipids and proteins, is known to accumulate in the lysosomes of aged cells (Stadtman, 1992) and brain cells of the patients with Alzheimer’s disease (Perry et al., 2002).

Different tissues have different sensitivity to oxidative damage, based on differences in ROS production, antioxidant molecules, enzymes, and the regenerative capacity of the tissue, for example, the neuronal tissue in general is more susceptible to oxidative damage. The high lipid content of the nervous tissue, in the form of myelin, with abundance of unsaturated fatty acids and long chain fatty acids in cell membranes, coupled with its high aerobic metabolic activity, make it particularly susceptible to oxidative damage (Floyd and Hensley, 2002).

Harman (1956) suggested that free radicals could be responsible for biological aging. Since then numerous studies have supported as well as contradicted this mitochondrial free-radical theory of aging (Alexeyev, 2009; Lapointe and Hekimi, 2010; Kitazoe et al., 2011). While the evidence for a simplistic idea of aging may not be conclusive, most diseases associated with the human aging process are known to have a strong oxidative stress component and this antioxidant defense generally reduces with age (Ames et al., 1993). The accumulation of net damage due to oxidative stress over a period of time is considered responsible for many age related disorders, Alzheimer’s disease, Parkinson’s disease, rheumatoid arthritis, cancers, and cardiovascular disorders, etc. (Gutteridge, 1993; Raha and Robinson, 2000; Halliwell, 2011). The flood of ROS generated in the neuronal and glial mitochondria during ischemic insults can be acutely devastating to the brain tissue (Aliev et al., 2002). Antioxidant stress is a major, if not primary mechanism linking obesity and metabolic disorders, especially insulin resistance or diabetes in animal models (Styskal et al., 2012) and alleviation of many symptoms is being reported in many studies by a regular consumption of antioxidants (Muellenbach et al., 2008, 2009; Curtis et al., 2010). Similar associations have been made between cardiac health and oxidative stress (Dai et al., 2012).

What are Antioxidants?

Cellular and tissue defense against oxidative damage can be both enzymatic and non-enzymatic. Superoxide dismutase [Mn-SOD, Cu/Zn-SOD, extracellular (EC)-SOD], catalase (CAT), glutathione paroxidase, glutathione reductase, peroxiredoxins are key enzymatic defenses and glutathione, thioredoxin, ascorbate (vitamin C), alpha-tocopherol (vitamin E), and uric acid are key non-enzymatic defenses (Poljsak, 2011). In generous terms, antioxidants also include carotenoids, manganese, reduced selenium, and alphalipoate, etc. (Smith et al., 1999; Ryan et al., 2010; Halliwell, 2011). This defense system is vulnerable to various environmental or external factors, which include pollution, drugs, radiation, and stress. Different antioxidants act to diminish the oxidative damage in vivo and their mechanism of action are highly varied.

Dietary Antioxidants and Their Impact on Health

A number of dietary antioxidants exist in herbal sources that are collectively known as phyto-antioxidants. Many plants consumed either as regular diet or as medicinal herbs reasons contain phyto-antioxidants. Various epidemiological studies have demonstrated the beneficial effects of high intake of fruits and vegetables in combating oxidative damage and other aging related problems (Eastwood, 1999). It is not obvious that whether this effect is achieved due to passive antioxidants or by boosting bodily antioxidant responses.

Many plants contain large amounts of polyphenols that can play an important role in adsorbing and neutralizing free radicals, quenching singlet and triplet oxygen, and decomposing peroxides. The majority of the antioxidant compounds belong to the family of flavonoids, lignans, and catechins. Due to the inefficiency of the endogenous defense system, in some physiopathological situations, increasing the amounts of dietary antioxidants is useful to diminish the cumulative effects of oxidative damage (Sun et al., 2002). In addition to the above compounds found in natural foods, vitamin C, vitamin E, carotene, and tocopherol, found in dietary sources are known to possess significant antioxidant potential (Cai et al., 2004; Tsao and Akhtar, 2005). While consumption of fruits and raw vegetables has been found to be very beneficial, passive antioxidant therapies have largely yielded mixed results, with some studies also showing significant negative impact on human health (Bjelakovic et al., 2004). This negative effect could be due to the global down-regulation of ROS pathways that are required for our immune system, many intracellular signaling pathways and the maintenance of hormesis effect that might be crucial in maintaining the intrinsic antioxidant response of our bodies in balance (Poljsak, 2011). Additional problems can include poor bioavailability of many passive antioxidants (Siow and Mann, 2010; Patel et al., 2011; Wallace, 2011). Given these problems with passive dietary antioxidants two possible approaches are likely going to be fruitful: regulation of ROS production and selective stimulation of specific intrinsic antioxidant pathways. In recent years NADPH oxidases have been targeted for their therapeutic potential in regulation of ROS production (Drummond et al., 2011). In this review we will focus on the stimulation of bodily enzymatic antioxidant pathways but it is also possible that the plant sources that we discuss may in future be found to even help regulate the production of ROS and not just have antioxidant responses.

Ayurvedic Plants with Potential of Providing Novel Antioxidant Stimulants

In the following text, we mention plants used in Indian pharmacopeia with their scientific name but we also provide English and Hindi names in parenthesis. Names in parenthesis, before the semi-colon are the English names and ones after, are the Hindi ones. Apart from the strictly dietary sources, many medicinal plants also provide antioxidants. Some such plants fall in both dietary and medicinal groups as they are used for both purposes. Few examples of plants used for both dietary and medicinal use that are rich in antioxidant effects are as follows: Allium cepa (onion; pyaaz), A. sativum (garlic; lahsuna), Aloe vera (Indian aloe, true aloe, medicinal aloe, Chinese aloe; ghritkumari), Camellia sinensis (green tea; chai), Cinnamomum verum (cinnamon; dal chini), C. tamala (Malabar leaf; tejpat), Curcuma longa (turmeric; haridra, haldar, haldi), Emblica officinalis (Indian gooseberry; amlaki), Glycyrrhiza glabra (liquorice; yashtimadhu, mulethi), Ocimum sanctum (holy basil; tulsi), Terminalia bellerica (beleric, bastard myrobalank; behda), Tinospora cordifolia (heart-leaved moonseed; guduchi), Trigonella foenum-graecum (fenugreek; methi), and Zingiber officinalis (ginger; adarak).

Apart from these dietary plants with medicinal value, ayurveda details strict medicinal plants that show strong antioxidant activities. “Rasayan Chikitsa” (Rasa = vital + Ayana = nourishment; chikitsa = treatment) is an important branch of ayurveda that deals with revitalization and rejuvenation in a holistic manner to slow aging and also to cure certain diseases. Sharangdhar in sixteenth century AD described Rasayanas as “Jaravyadhi Vinasanam” which literal means checking the advancement of age (Jara = age) as well as destroyer (Vinasanam = destruction) of disease (Vyadhi = disease; Rastogi, 2010). The modern scientific evaluation of some of the major Vayahsthapan (anti-aging) rasayanas and Jeevaniya (life-promoting) rasayanas shows that most of these anti-aging drugs have antioxidant properties, besides several other pharmacological actions (Rastogi et al., 1998; Anekonda and Reddy, 2005). Many passive antioxidants are already extracted and commercialized from dietary sources in addition to the synthetic compounds (Shahidi, 1997), so we have not cataloged over hundreds of plants that are generally rich in phyto-antioxidants. The examples we discuss are either known to have or have a good chance to have compounds that stimulate intrinsic antioxidant machinery of the human body. These plants also happen to have passive antioxidant compounds in large quantities that we mention in chemical constituents. The ultimate goal of this review is to emphasize the need of curing oxidative damage related problems by stimulating the intrinsic antioxidant machinery of the body, instead of just treating the symptoms using passive dietary antioxidants. Following are some select Auyrvedic plants with description of their sources, traditional uses, modern verification of some of their uses, and their antioxidant potential. A summary of these plants is presented in Table 1.

Table 1.

Plants with known or likely antioxidant stimulating effects.

Plant Antioxidant responses Active antioxidant effects and known or putative compounds
Withania somnifera Active stimulation and passive antioxidants Stimulation due to sitoindosides VII–X and withaferin A (glycowithanolides; Bhattacharya et al., 1997; Vimal et al., 2010)
Centella asiatica Active stimulation and passive antioxidants Enhances glutathione levels, thiols, and antioxidant defenses (Shinomol and Muralidhara, 2008; Shinomol et al., 2010). Antioxidant in three pathways: superoxide free-radical activity inhibition of linoleic acid peroxidation and 2,2-diphenyl-1-picryl-hydrazyl (DPPH) radical scavenging activity (Vimala et al., 2003; Pittella et al., 2009). Reduces monamine levels that can spontaneously auto-oxidize to free radicals (Bindoli et al., 1992). Exact compounds remain to be identified
Asparagus racemosus Active stimulation and passive antioxidants Prevents decline in GPX activity and reduction in glutathione (GSH) content and reduces membrane lipid peroxidation and protein carbonyl content (Parihar and Hemnani, 2004). Compensates reduction in the superoxide dismutase, catalase, ascorbic acid, and lactate dehydrogenase levels and lowers the heightened MDA levels (Vimal et al., 2010). Exact compounds remain to be identified
Acorus calamus Active stimulation and passive antioxidants Decrease GSH and GST and increase dopamine receptors (Shukla et al., 2002). Increases the activities of major enzymes of the antioxidant defense system, especially SOD, CAT, and GPX and the levels of GSH and decrease in the formation of MDA (Sandeep and Nair, 2010). Exact compounds remain to be identified
Bacopa monnieri Active stimulation and passive antioxidants Bacopa monnieri extracts modulate the expression of certain enzymes involved in the generation and the scavenging of reactive oxygen species in the brain (Govindarajan et al., 2005). Exact compounds remain to be identified
Celastrus peniculatus Active stimulation and passive antioxidants Causes significant decrease in the brain levels of MDA and increases in levels of glutathione and catalase (Kumar and Gupta, 2002). Superoxide dismutase activity is unaffected by extracts but catalase activity is increased and MDA levels are reduced (Godkar et al., 2006). Exact compounds remain to be identified
Convulvulus pleuricaulis Known passive antioxidants only Given the antioxidant effects it is likely that there is likely stimulation of active antioxidant responses too that yet remains to be characterized
Curcuma longa Known passive antioxidants only Given the antioxidant effects it is likely that there is likely stimulation of active antioxidant responses too that yet remains to be characterized

Withania somnifera (dunal; aswagandha, asgandhi, asoda, and amukkira)

Geographical distribution and ethnomedical description

Withania somnifera shrub that grows wild in India, is widely distributed across Africa, Europe, and Asia. It is commonly referred to as Ashwagandha (Ashwa = horse + Gandha = smell) in Sanskrit and Hindi because of its smell. In ayurveda, W. somnifera herbal remedy consists of the use of dried roots and stem bases of the plant. In traditional system it is used as anti-inflammatory and antitumor agent, immunity booster, and aphrodisiac for both men and women, though many of these effects have yet to be evaluated by modern means.

Chemical constituents

The chemistry of W. somnifera has been extensively studied and over 35 chemical constituents have been identified, extracted, and isolated (Rastogi et al., 1998). The biologically active chemical constituents are alkaloids (isopelletierine, anaferine), steroidal lactones (withanolides, withaferins), saponins containing an additional acyl group (sitoindoside VII and VIII), and withanolides with a glucose at carbon 27 (sitoindoside IX and X; Rastogi et al., 1998).

Active antioxidant and other roles

Animal stress studies have investigated the use of this herb as an antistress agent (Dadkar et al., 1987; Dhuley, 1998; Archana and Namasivayam, 1999), therapeutic in depression (Ramanathan et al., 2003) and explored its antioxidant properties (Panda and Kar, 1997). The active principles of W. somnifera – sitoindosides VII–X and withaferin A (glycowithanolides), have been tested for their antioxidant stimulant activity by measuring the levels of major free-radical scavenging enzymes, such as SOD, CAT, and glutathione peroxidase (GPX) levels in the rat brain frontal cortex and striatum (Vimal et al., 2010). Active glycowithanolides of W. somnifera show a dose dependent increase in activity of all these enzymes, to a level similar to seen with intraperitoneal administration of deprenyl, a known antioxidant (Bhattacharya et al., 1997). While, such strong active antioxidant effects have been reported, the exact active ingredients responsible for this stimulation of the innate antioxidant machinery remain to be identified (Bhattacharya et al., 1997). While large doses of ashwagandha may possess abortifacient properties and it can act as a mild central nervous system (CNS) depressant, in most cases ashwagandha appears to be very safe, with an LD50 of a 50% alcohol extract determined to be 1 g/kg in rats (Aphale et al., 1998; Williamson, 2002). Caution should be used with patients on anticonvulsants, barbiturates, and benzodiazepines due to its GABA-nergic and sedative properties (Mehta et al., 1991; Kulkarni et al., 2008; Bhattarai et al., 2010).

Centella asiatica (Linn.) urban (Indian pennywort; brahmi, manduka parani, mandooki, divya, bhekaparni)

Geographical distribution and ethnomedical description

Centella asiatica is a small creeping herbaceous plant found in damp, shady places throughout the tropical regions of the world. C. asiatica finds mention in Shsruta samhita and is an important component of the Indian pharmacopeia (Nadkarni, 1910). In ayurveda, C. asiatica parts are considered useful in the diseases of skin, nervous system, and blood. The leaves are the only recognized part in traditional pharmacopeia of India, but many modern investigators have advocated the use of entire plant, root, twigs, leaves, and seeds in medicine (Hamid et al., 2002; Sudarshan, 2005).

Chemical constituents

Centella contains high concentration of metal ions potassium, calcium, phosphorus, iron, and sodium. It is low in protein, carbohydrate, fat, and crude fibers but rich in vitamin C, B1, B2, niacin, carotene, and vitamin A (Tee et al., 1997). The biologically active components of Centella plant are believed to be triterpenes and saponins (Loiseau and Mercier, 2000). The triterpenes of Centella are composed of many compounds including asiatic acid, madecassic acid, asiaticosside, madecassoside, brahmoside, brahmic acid, brahminoside, thankiniside, isothankunisode, centelloside, madasiatic acid, centic acid, and cenellic acid (Zheng and Qin, 2007). Among these triterpenes, the most important biologically active compounds are the asiatic acid and madecassic acid (Inamdar et al., 1996). C. asiatica contains triterpene glycosides such as centellasaponin, asiaticoside, madecassoside, and sceffoleoside (Matsuda et al., 2001). The content of Centella’s triterpene components can be affected by the location and diverse environmental conditions (James and Dubery, 2009). Centella also contains high total phenolic contents in the form of flavonoids such as quercetin, kaempherol, catechin, rutin, apigenin, and naringin and volatile oils such as caryophyllene, farnesol, and elemene (Qin et al., 1998).

Active antioxidant and other roles

Preliminary modern studies have demonstrated some beneficial effects in neuronal function, ulcers, liver functions, and immune responses (Warrier et al., 1996; Dash and Jounious, 1997; Frawley and Lad, 2004). Centella impedes brain aging and improves attention problems (Singh et al., 2008). Besides this, Centella is also reported to be useful in improving learning scores in young mice (Rao et al., 2005), providing protection against neurodegeneration (Ramanathan et al., 2007), neuroprotection against oxidative stress in the brain of prepubertal mice, enhancing glutathione levels, thiols, and antioxidant defenses (Shinomol and Muralidhara, 2008; Shinomol et al., 2010). C. asiatica extracts can influence the morphology of hippocampal CA3 and amygdalar neuronal dendritic arborization in neonatal rats (Rao et al., 2006, 2009) and can have anxiolytic effect in animals comparable to diazepam (Chen et al., 2006). Patients of anxiety necrosis showed reduced anxiety levels and showed improvement in the mental fatigue rate and immediate memory after a C. asiatica regimen (Bradwejn et al., 2000; Jana et al., 2010) and Centella attenuates d-galactose-induced behavioral, biochemical, and mitochondrial dysfunction by involving antioxidant and mitochondrial pathways in the senescent mice (Kumar et al., 2011). Brahminoside exhibits a CNS-depressant effect in mice and rats (Ramaswamy et al., 1970). In an old clinical study, C. asiatica regimen showed improvement in mental health of mentally challenged children (Rao and Rao, 1973). Whether these effects are predominantly due to active antioxidant stimulation, passive antioxidants, or other mechanisms is not fully known. C. asiatica extracts have been reported to increase brain GABA levels (Chatterjee et al., 1992), suggesting neuromodulation to also underlie some of its neuroactive actions. Beside the triterpenes, the antioxidant protection effect of Centella is likely contributed by its passive antioxidants in the form of enriched flavonoids and selenium content (Ponnusamy et al., 2008). Among the triterpenes isolated from Centella plant, asiaticoside is the most abundant and responsible for stimulating the antioxidant activity in the early phase of the wound healing process (Shukla et al., 1999). In vitro studies have found high antioxidant activity of leaves of Centella in three pathways: superoxide free-radical activity (86.4%), inhibition of linoleic acid peroxidation (98.2%), and 2,2-diphenyl-1-picryl-hydrazyl (DPPH) radical scavenging activity (92.7%; Vimala et al., 2003; Pittella et al., 2009). In addition to its antioxidant activity, asiaticoside has been reported as being helpful in reducing dementia and enhancing cognition (De Souza et al., 1990) and found to have therapeutic value against β-amyloid neurotoxicity (Mook-Jung et al., 1999). Protection from oxidative damage, apart from encompassing both the direct passive antioxidants and the stimulants of enzymes involved in antioxidant defense, also encompasses a reduction in monamine levels because these compounds can spontaneously auto-oxidize to free radicals (Bindoli et al., 1992). Centella is useful even in this way of monamine reduction to counter oxidative damage. There is concern that Centella might cause liver damage in some people and cause side effects like stomach upset, nausea, and itching (Jorge and Jorge, 2005).

Asparagus racemosus Wild (Asparagus; Shatavari, Shatuli, Vrishya) Geographical distribution and ethnomedical description: A. racemosus is commonly known as Shatavari in India. Romans used A. racemosus for food and medicinal purpose. It was first cultivated in England at the time of Christ and brought to America by the early colonists. Shatavari has great reputation in ayurveda for relief in uterine diseases, to increase lactation, as an antacid, and as a tonic. Chemical constituents: The major bioactive constituents of Asparagus are a group of steroidal saponins. This plant also contains vitamins A, B1, B2, C, E, and folic acid. Asparagus also contains metals like Mg, P, Ca, and Fe. Other primary chemical constituents of Asparagus are essential oils, asparagine, arginine, tyrosine, flavonoids (kaempferol, quercetin, and rutin), resin, and tannin (Bopana and Saxena, 2007). Shatavarins I–IV, major steroidal saponins are present in the roots. Five steroidal saponins, shatavarins VI–X, shatavarin V, immunoside, and schidigerasaponin D5, have been isolated from the roots of A. racemosus (Hayes et al., 2008). Other active compounds such as quercetin, rutin, and hyperoside are found in the flowers and fruits, while diosgenin and quercetin-3 glucuronide are present in the leaves (Asmari et al., 2004). Asparagus is also rich in phytoestrogens, namely the isoflavones and coumastans (Bopana and Saxena, 2007).

Active antioxidant and other roles

Shatavari is used for sexual debility and infertility in both sexes in some modern studies. It has been used to ameliorate menopausal symptoms (Thakur et al., 1989). The herb is widely reported for galactagogue activity (Atal and Kapur, 1982; Thakur et al., 1989; Shah and Qadry, 1990). It is also known for its nootropic effects (Ojha et al., 2010). Further, methanolic Asparagus extract dose-dependently inhibited acetylcholinesterase enzyme in specific brain regions (prefrontal cortex, hippocampus, and hypothalamus; Ojha et al., 2010). These activities may be related to the augmentation of cholinergic transmission as methanolic Asparagus extract significantly inhibited the enzyme cholinesterase. Gindi (2011) further explored these nootropic effects by using scopolamine-induced memory deficit and AlCl3 induced cognitive deficits in rats. The nootropic effects could be in part due to the observed increase in the antioxidant activity in terms of DPPH radical and NO radical scavenging activity (Gindi, 2011).

The extracts of A. racemosus protect against kainic acid induced hippocampal and striatal neuronal damage that is accompanied by an increase in lipid peroxidation and protein carbonyl content, decline in GPX activity, and reduced glutathione (GSH) content (Parihar and Hemnani, 2004). The Asparagus extract supplemented mice show an improvement in the GPX activity and the GSH content and a reduction in the membrane lipid peroxidation and protein carbonyl content (Parihar and Hemnani, 2004). Similar to kanic acid induced insult, immobilization stress induced oxidative changes in the hippocampal subregion are also counteracted by the antioxidant effects of Asparagus extracts (Vimal et al., 2010). Treatment with the Asparagus extract compensates the immobilization stress induced decrease in the SOD, catalase, ascorbic acid, and lactate dehydrogenase levels and lowers the heightened MDA levels (Vimal et al., 2010). Renal pain, peripheral edema, exacerbation of gout, and skin allergies have been reported for a small number of patients (Chrubasik et al., 2006). Lipid transfer proteins, profilin, and glycoproteins may account for the reactions as well as for cross-sensitivities of Asparagus (Pajno et al., 2002; Rieker et al., 2004; Tabar et al., 2004; Volz et al., 2005).

Acorus calamus Linn. (sweet flag, calamus; bach, vacha)

Geographical distribution and ethnomedical description

Acorus calamus L. is a polyploidic marsh plant indigenous to Asia that is now distributed along trade routes all over the northern hemisphere. The aromatic rhizome has been widely used as an herbal remedy. Ayurvedic medicine and traditional Chinese medicine use the drug to treat CNS related diseases such as epilepsy and insomnia (Williamson, 2002; Khare, 2004). In European folk medicine, A. calamus rhizomes have been mainly used to alleviate gastrointestinal ailments such as acute and chronic dyspepsia, gastritis and gastric ulcer, intestinal colic, and anorexia.

Chemical constituents

Its extract contains monoterpenes, sesquiterpenes, phenylpropanoids, range of sesquiterpene hydrocarbons, alcohols, and ketones (e.g., acorone, acoragermacrone, calamendiol) besides eugenol, methyl isoeugenol, and phenyl propane derivatives such as α and β-asarone (Raina et al., 2003). Interestingly β-asarone content in Acorus is possibly dependent upon the genetic composition of plant as the volatile oil from the tetraploid “Indian” form of calamus contains β-asarone as a major component (up to 95%) whereas the oil from the “European” or triploid form contains less than 10% β-asarone (Lander and Schreier, 1990). A diploid form of the plant contains virtually no β-asarone (Lander and Schreier, 1990).

Active antioxidant and other roles

Several in vivo studies support a sedative and tranquilizing action of the extracts of A. calamus (Dandiya et al., 1959; Dandiya and Menon, 1963; Vohora et al., 1990). The tranquilizing effect has been suspected to be due to α-asarone and β-asarone (Dandiya and Menon, 1963; Liao et al., 1998; Zanoli et al., 1998) but up to now the underlying mechanisms of action of these compounds has not been convincingly demonstrated. The ethanolic extract of Acorus calamus has been shown in a report to prevent acrylamide-induced hind limb paralysis, decrease GSH and GST, and increase dopamine receptors in the corpus striatum (Shukla et al., 2002). Acorus is effective in attenuating the noise stress via scavenging free radicals and lowering the lipid peroxidation in many regions of the rat brain, like cerebral cortex, cerebellum, pons-medulla, midbrain, hippocampus, and hypothalamus (Manikandan et al., 2005). Acorus calamus extract exhibit radioprotection abilities in part due to antioxidant activity by increasing the activities of major enzymes of the antioxidant defense system, especially SOD, CAT, and GPX and the levels of GSH and decrease in the formation of MDA and in part due to the reduction in DNA strand breaks (Sandeep and Nair, 2010).

Bacopa monnieri (Linn) wettst. (Coastal waterhyssop; Nirbrahmi)

Geographical distribution and ethnomedical description

Bacopa monnieri is commonly found in wet marshy and damp places throughout India. Occasionally it is also referred to Brahmi, the same common Hindi name as that of C. asiatica. A disambiguating and more appropriate Hindi name is Nirbrahmi (Nir = water + Brahmi) indicating the marshy habitat of Bacopa. The ambiguity, likely introduced in the sixteenth century, still persists in the common usage due to a big overlap in the medicinal value of the two herbs. B. monnieri is a major constituent of the traditional Medhya rasayana (Medhya = intelligence, Rasayana = rejuvenators) formulations, which are considered to facilitate learning and improve memory (Garai et al., 1996). In traditional medicine, the plant is used as nervine tonic, diuretic, and to treat asthma, epilepsy, insanity, and hoarseness.

Chemical constituents

Pharmacological compounds from B. monnieri include alkaloids, saponins, and sterols. It also contains the brahmine, herpestine, saponins, monnierin, hersaponin, bacosides, four aglycones of ebelin, lactone (Kulshreshtha and Rastogi, 1973), bacogenins A1 (Kulshreshtha and Rastogi, 1973; Chandel et al., 1977), jujubogenin, and pseudojujubogenin (Kawai and Shibata, 1978), d-mannitol, betulic acid, β-sitosterol, stigmasterol and its esters, heptacosane, octacosane, non-acosane, triacontane, hentriacontane, dotriacontane, nicotine, 3-formyl-4-hydroxy-2H-pyran, and luteolin and its derivatives (Rastogi and Mehrotra, 1990).

Active antioxidant and other roles

Bacopa monnieri extract shows neuroprotective effect against neurotoxicants like aluminum and nicotine in experimental animals (Jyoti and Sharma, 2006; Vijayan and Helen, 2007). In one study, B. monnieri extract was shown to reduce the amyloid levels in a Alzheimer’s disease model mice, suggestive of its therapeutic potential (Holcomb et al., 2006) and we think further studies are needed to explore this issue further. In one study, the oral administration of 5–10 mg B. monnieri crude extract per kg body weight markedly reduced the memory deficits in rats along with a reduction in acetylcholine concentrations, choline acetylase activity, and muscuranic receptor binding in the hippocampus and the frontal cortex (Dhawan and Singh, 1996). B. monnieri also helps in coping with combined hypoxic, hypothermic, and ischemic stress that could lead to the onslaught of free radicals (Rohini et al., 2004). Studies suggest that Bacopa extracts scavenge superoxide anion and hydroxyl radical and reduce H2O2 induced cytotoxicity and DNA damage in human fibroblast cells (Tripathi et al., 1996; Rai et al., 2003). B. monnieri extracts modulate the expression of certain enzymes involved in the generation and the scavenging of ROS in the brain (Govindarajan et al., 2005). Bacosides from B. monnieri are known for their antioxidant activity (Tripathi et al., 1996; Bhattacharya et al., 2000; Deb et al., 2008), for example bacoside A has been shown to offer significant protection against chronic cigaret smoking-induced oxidative damage in rat brains (Anbarasi et al., 2006). The antioxidant activity of B. monnieri is able to explain, at least in part, the reported antistress, cognition-facilitating, and ant-aging effects produced by it in experimental animals and in clinical situations. In a study, when a preparation of the plant was evaluated for safety and tolerability it showed no serious adverse effects but there were some reports of mild gastrointestinal symptoms (Pravina et al., 2007).

Celastrus peniculatus Willd. (climbing staff tree, intellect tree; Mal-kangani)

Geographical distribution and ethnomedical description

Celastrus paniculatus is a large, woody, climbing shrub, distributed almost all over India. In traditional medicine the seeds are considered to be stimulant, intellect promoting, laxative, emetic, expectorant, appetizer, aphrodisiac, cardiotonic, anti-inflammatory, and diuretic (Chopra and Chopra, 1958; Warrier et al., 1996; Bhanumathy et al., 2010). It has also been traditionally used for healing abdominal disorders, leprosy, pruritus, skin diseases, paralysis, cephalalgia, arthralgia, asthma, leucoderma, cardiac debility, inflammation, nephropathy, amenorrhoea, dysmenorrhoea, beri-beri, and sores (Chopra and Chopra, 1958; Warrier et al., 1996; Bhanumathy et al., 2010). In traditional medicine the bark is considered to be an abortifacient, a depurative and a brain tonic and the leaves as emmenagogue and the leaf sap, a good antidote for opium poisoning (Chopra and Chopra, 1958; Warrier et al., 1996; Bhanumathy et al., 2010).

Chemical constituents

Celastrus peniculatus contains several possible active ingredients like polyalcohols, malkanguniol (Hertog et al., 1974), β-sitosterol, β-amyrin, a pentacyclic triterpene diol paniculatadiol (Hertog et al., 1973), several phytosteroids, saponins, and tannins (Joshi and Sabnis, 1989), n-triacontanol, pristimerin (Jain, 1963), celastrol, pristimerin, zeylasterone, and zeylasteral (Gamlath et al., 1990).

Active antioxidant and other roles

Celastrus peniculatus has been reported for stimulatory effects on brain (Warrier et al., 1996). In an old study it was found to enhance memory and improve the IQ of mentally retarded children (Morris et al., 1953). The seed extract of C. paniculatus demonstrate improvements in learning abilities in mice along with improvements in antioxidant activity in the form of significant decrease in the brain levels of MDA and increases in levels of glutathione and catalase (Kumar and Gupta, 2002). Celastrus extracts can attenuate hydrogen peroxide and glutamate-induced injury in embryonic rat forebrain neuronal cells, in a dose dependent manner (Godkar et al., 2006). SOD activity was unaffected after treatment, in comparison to this catalase activity was increased and MDA levels were reduced (Godkar et al., 2006).

Convulvulus pleuricaulis Choisy. (Bindweed; Kaudiali, Shankhahuli, Shankhpushpi)

Geographical distribution and ethnomedical description

Convolvulus pleuricaulis is used in traditional systems of medicine in anxiety, neurosis, insanity, epilepsy, insomnia, fatigue, low energy level, and as a brain tonic (Sethiya and Mishra, 2010). Traditionally the whole herb is used medicinally in the form of decoction with cumin and milk in nervous debility, and loss of memory (Chopra and Chopra, 1958; Warrier et al., 1996). This plant is widely distributed across Indian subcontinent.

Chemical constituents

Convolvulus contains neuroactive alkaloids such as shankhpushpine, convolamine, and other likely potent compounds such as hextriacontane (Deshpande and Srivastava, 1975), scopoletin, P-sitosterol and ceryl alcohol (Deshpande and Srivastava, 1969), 20-oxodotriacontanol, tetratriacontanoic acid and 29-oxodotriacontanol, flavonoid kampferol and phytosteroids such as phytosterol and P-sitosterol (Singh and Bhandari, 2000).

Active antioxidant and other roles

Supporting the long-standing belief and extensive large-scale commercial use in India of the aqueous extract of Convolvulus, a recent rodent study showed significant improvement in learning by finding reduction in scopolamine induced increase in the transfer latency in the elevated plus maze and improvement in the impaired spatial memory in the Morris water maze (Bihaqi et al., 2011). Extract was also found to decrease acetylcholinesterase activity in the cortex and hippocampal subregion and increase the activity of glutathione reductase, SOD, and GSH (Bihaqi et al., 2011). Whether the learning boosting effects were solely due to antioxidant activity in the above-mentioned study is not obvious but the potential of this plant for finding active stimulants of antioxidant pathway seems very high. Significant antioxidant boosting and acetylcholinesterase inhibitory properties have previously been observed too (Nag and De, 2008). Extracts of convolvulus have also been shown to reduce the increased levels of MDA along with altering glutathione levels in hippocampus (Parihar and Hemnani, 2003). In summary, studies demonstrate the potential of C. pleuricaulis for being a promising source of novel stimulants of antioxidant responses.

Curcuma longa Linn. (Turmeric; Haldi)

Geographical distribution and ethnomedical description

Curcuma longa known commonly as Haldi is perennial rhizome plant grows also all over India. Its antioxidant potential is well demonstrated and many compounds commercialized. Given the ease of availability of information on this plant (Ammon and Wahl, 1991; Park and Kim, 2002; Singh et al., 2002; Basnet and Skalko-Basnet, 2011; Schaffer et al., 2011; Mythri and Bharath, 2012), we are keeping discussion of this herbal source to a minimum.

Chemical constituents

Curcuma contains phenylheptanoids, monoterpenes, ses-quiterpenes, several diphenyl alkanoids, phenyl propene derivatives of cinnamic acid type, and terpenoids, along with very active and well studied compound: curcumin (Roth et al., 1998; Park and Kim, 2002; Singh et al., 2002). The rhizomes contains curcuminoids, curcumin, demethoxy curcumin, bis-demethoxycurcumin, 5′-methoxycurcumin, and dihydrocurcumin that are known antioxidants (Ravindranath and Satyanarayana, 1980; Kiuchi et al., 1993; Nakayama et al., 1993; Park and Kim, 2002).

Active antioxidant and other roles

Methanol extract of turmeric has led to the isolation of Calebin-A and some curcumin compounds that are claimed to offer a good degree of protection to the neuronal cells against β-amyloid deposition (Park and Kim, 2002). Oral administration of curcumin to alcohol-fed rats causes a significant reversal of brain lipid peroxidation, indicating its neuroprotective role (Rajakrishnan et al., 1999). Curcuminoids have been found to be potent inhibitors of lipid peroxidation, inhibiting lipid peroxidation in rat brain homogenates, and rat liver microsomes to a higher level than alpha-tocopherol (Rao, 1994). It is not clear whether the antioxidant potential of turmeric is due to rich passive antioxidants that it contains or due to additional active antioxidant stimulating compounds. While the use of turmeric in food and monitored quantities as medicine is very safe, very high doses of C. longa (500 mg/kg) have been reported to induce chromosomal aberrations in animal models (Jain et al., 1987), suggesting need for caution when selecting the medicinal dose.

Bioavailability of Herbal Drugs and Antioxidant Property

Bioavailability has been broadly defined as “absorption and utilization of a nutrient” (Krebs, 2001). The degree and quantity of penetration of herbal drug or its active ingredient is determined by its bioavailability (Youdim et al., 2004; Reddy et al., 2005). Bioavailability of ayurvedic herbal drugs has been largely neglected and only some studies have conducted fine quantitative measurements, for example measurement of baicalein found in T. arjuna (Tilak et al., 2006). Bioavailability can depend on chemical complexity of the herb due to synergistic and antagonistic actions of the constituents in promoting absorption, hydrophobic properties determining the ability to cross luminal wall, gut microflora, and hepatic activity of the individual, and chemical modifications of the herbal constituents. Constituents in herbal drugs must cross the blood brain barrier to be effective in the CNS and there is a dearth of literature on Indian herbs, especially ones with bodily antioxidant stimulating potential on such an important topic. Synergistic interactions of herbs can play an important role in bioavailability, like capsicum can increase the availability of theophylline (Bouraoui et al., 1986) and tamarind can increase the bioavailability of Asprin (Mustapha et al., 1996). Atal et al. (1981) demonstrated that long pepper, black pepper, and ginger can increase bioavailability of some compounds. There is evidence of considerable person-to-person variation in gut microflora and hepatic activity too (Williamson and Manach, 2005). A look at turmeric extracts in the context of non-oxidative issues can bring to light the problem of a compound or an extract working in vitro failing to work in vivo because of issues of bioavailability (Basnet and Skalko-Basnet, 2011; Belkacemi et al., 2011; Irving et al., 2011).

Conclusion

While ayurvedic plants have been explored for many passive antioxidants and medical uses for serious neurological diseases such as Alzheimer’s disease (Anekonda and Reddy, 2005), a systematic analysis for the herbs covered in this review for the ability to increase body’s ability to reduce antioxidant stress has been previously missing. In the present review we provide bodily antioxidant stimulating potential of selected Indian medicinal plants used in traditional medicine system of ayurveda. We speculate that the cases where traditional medicine actually works successfully beyond a placebo effect, it is likely due to the effect of herbal extracts on multiple nodes of the signaling pathway, instead of single target approach of the Western medicine. Our focus has been on plants that can likely yield direct stimulants of physiological antioxidant response. Reasons to identify, synthesize, and modify the active compounds of traditional herbs instead of using the traditional formulae alone are as follows:

  1. Many of the supposed effects of some traditional medicine are simply placebo and it is important to disambiguate real effects of herbs from placebo effects.

  2. In absence of concentrating the active compounds beyond extracts most traditional medicines usually can only aid slow recovery from disease but do not offer fast solutions.

  3. The extracts of a plant can have components that have opposing effects. For example C. asiatica is rich in many pro-oxidative metals, while being a rich source of passive and active antioxidants.

  4. Many of the components of certain plants can be allergens to some patients and isolation of active components would eliminate allergens and other contaminants.

  5. Many of the passive antioxidants that are known to be good antioxidants in vitro are considered to be at best just weak antioxidants in vivo. In fact, some studies suggest that pro-oxidative activities of flavanoids outweigh antioxidant activities in vivo (Procházková et al., 2011). This necessitates the need for finding agents that can stimulate body’s own antioxidant response. Most of the plants that we cover have been shown to stimulate intrinsic antioxidant responses in humans.

While it is important to isolate and modify the active compounds from Indian pharmacopeia, it is equally important to understand that some of the efficacy of these preparations may be due to multiple active components that act synergistically in herbal concoctions, hence a single molecule stimulant of antioxidant responses may not be the end point in pharmaceutical development for all the above-mentioned plants.

While we have focused on traditional medicines that have been clinically tested and evaluated by modern means, we would like to point out that the technical finesse and rigor of many studies leaves a large room of improvement. Funding issues and cultural biases mean that currently most cutting edge laboratories shy away from exploring these traditional medicines. Many of the clinical studies that have looked at the Indian traditional medicine, have so far been small scale and many have lacked a systematic evaluation of multiple parameters of patient health that are increasingly becoming the norm for clinical trials. Clinical studies using traditional medicine have also rarely been double blind leaving chance of physician’s bias in some of the reported studies. While the state-of-the-art exploration of these herbal sources has been a minority of research in this field so far, we expect significant improvement in research the near future. The reason to expect such a change, apart from cultural and attitude shift amongst biologists is the dire need of active antioxidants that can help patients deal with many chronic ailments, aging problems, and neurodegenerative disorders. While Western medicine has failed on most counts to deliver such active antioxidants, modern studies of many ayurvedic plants mentioned in this review have been very promising, necessitating their future exploration. We expect that a modern systems biology approach toward studying physiology, epigenomics, transcriptomics, proteomics, and metabolomics, apart from standard reductionist approaches, will be employed in exploring the potential of few traditional medicines that we have enumerated in this review.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

References

  1. Alexeyev M. F. (2009). Is there more to aging than mitochondrial DNA and reactive oxygen species? FEBS J. 276, 5768–5787 10.1111/j.1742-4658.2009.07269.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aliev G., Seyidova D., Neal M. L., Shi J., Lamb B. T., Siedlak S. L., Vinters H. V., Head E., Perry G., Lamanna J. C., Friedland R. P., Cotman C. W. (2002). Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice. Ann. N. Y. Acad. Sci. 977, 45–64 10.1111/j.1749-6632.2002.tb04798.x [DOI] [PubMed] [Google Scholar]
  3. Ames B. N. (2004). Delaying the mitochondrial decay of aging. Ann. N. Y. Acad. Sci. 1019, 406–411 10.1196/annals.1297.073 [DOI] [PubMed] [Google Scholar]
  4. Ames B. N., Shigenaga M. K., Hagen T. M. (1993). Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. U.S.A. 90, 7915–7922 10.1073/pnas.90.17.7915 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ammon H. P., Wahl M. A. (1991). Pharmacology of Curcuma longa. Planta Med. 57, 1–7 10.1055/s-2006-960004 [DOI] [PubMed] [Google Scholar]
  6. Anbarasi K., Vani G., Balakrishna K., Devi C. S. (2006). Effect of bacoside A on brain antioxidant status in cigarette smoke exposed rats. Life Sci. 78, 1378–1384 10.1016/j.lfs.2005.07.030 [DOI] [PubMed] [Google Scholar]
  7. Anekonda T. S., Reddy P. H. (2005). Can herbs provide a new generation of drugs for treating Alzheimer’s disease? Brain Res. Brain Res. Rev. 50, 361–376 10.1016/j.brainresrev.2005.09.001 [DOI] [PubMed] [Google Scholar]
  8. Aphale A. A., Chhibba A. D., Kumbhakarna N. R., Mateenuddin M., Dahat S. H. (1998). Subacute toxicity study of the combination of ginseng (Panax ginseng) and ashwagandha (Withania somnifera) in rats: a safety assessment. Indian J. Physiol. Pharmacol. 42, 299–302 [PubMed] [Google Scholar]
  9. Archana R., Namasivayam A. (1999). Antistressor effect of Withania somnifera. J. Ethnopharmacol. 64, 91–93 10.1016/S0378-8741(98)00107-X [DOI] [PubMed] [Google Scholar]
  10. Asmari S., Zafar R., Ahmad S. (2004). Production of sarsasapogenin from tissue culture of Asparagus racemosus and its quantification by HPTLC. Iran. J. Pharm. Res. 3, 66–67 [Google Scholar]
  11. Atal C. K., Kapur B. M. (1982). Cultivation and Utilization of Medicinal Plants. Jammu-Tawi: Regional Research Laboratory, Council of Scientific & Industrial Research [Google Scholar]
  12. Atal C. K., Zutshi U., Rao P. G. (1981). Scientific evidence on the role of Ayurvedic herbals on bioavailability of drugs. J. Ethnopharmacol. 4, 229–232 10.1016/0378-8741(81)90029-5 [DOI] [PubMed] [Google Scholar]
  13. Barelli S., Canellini G., Thadikkaran L., Crettaz D., Quadroni M., Rossier J. S., Tissot J. D., Lion N. (2008). Oxidation of proteins: basic principles and perspectives for blood proteomics. Proteomics. Clin. Appl. 2, 142–157 10.1002/prca.200780009 [DOI] [PubMed] [Google Scholar]
  14. Basnet P., Skalko-Basnet N. (2011). Curcumin: an anti-inflammatory molecule from a curry spice on the path to cancer treatment. Molecules 16, 4567–4598 10.3390/molecules16064567 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Belkacemi A., Doggui S., Dao L., Ramassamy C. (2011). Challenges associated with curcumin therapy in Alzheimer disease. Expert Rev. Mol. Med. 13, e34. 10.1017/S1462399411002055 [DOI] [PubMed] [Google Scholar]
  16. Bhanumathy M., Harish M. S., Shivaprasad H. N., Sushma G. (2010). Nootropic activity of Celastrus paniculatus seed. Pharm. Biol. 48, 324–327 10.3109/13880200903127391 [DOI] [PubMed] [Google Scholar]
  17. Bhattacharya S. K., Bhattacharya A., Kumar A., Ghosal S. (2000). Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytother. Res. 14, 174–179 10.1002/1099-1573(200011)14:7<568::AID-PTR663>3.0.CO;2-Q [DOI] [PubMed] [Google Scholar]
  18. Bhattacharya S. K., Satyan K. S., Chakrabarti A. (1997). Effect of Trasina, an Ayurvedic herbal formulation, on pancreatic islet superoxide dismutase activity in hyperglycaemic rats. Indian J. Exp. Biol. 35, 297–299 [PubMed] [Google Scholar]
  19. Bhattarai J. P., Ah Park S., Han S. K. (2010). The methanolic extract of Withania somnifera ACTS on GABAA receptors in gonadotropin releasing hormone (GnRH) neurons in mice. Phytother. Res. 24, 1147–1150 [DOI] [PubMed] [Google Scholar]
  20. Bihaqi S. W., Singh A. P., Tiwari M. (2011). In vivo investigation of the neuroprotective property of Convolvulus pluricaulis in scopolamine-induced cognitive impairments in Wistar rats. Indian J. Pharmacol. 43, 520. 10.4103/0253-7613.84958 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Bindoli A., Rigobello M. P., Deeble D. J. (1992). Biochemical and toxicological properties of the oxidation products of catecholamines. Free Radic. Biol. Med. 13, 391–405 10.1016/0891-5849(92)90182-G [DOI] [PubMed] [Google Scholar]
  22. Bjelakovic G., Nikolova D., Simonetti R. G., Gluud C. (2004). Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 364, 1219–1228 10.1016/S0140-6736(04)17138-9 [DOI] [PubMed] [Google Scholar]
  23. Bopana N., Saxena S. (2007). Asparagus racemosus – ethnopharmacological evaluation and conservation needs. J. Ethnopharmacol. 110, 1–15 10.1016/j.jep.2007.01.001 [DOI] [PubMed] [Google Scholar]
  24. Bouraoui A., Toumi A., Bouchacha S., Boukef K., Brazier J. L. (1986). Influence de l’alimentation épicéé et piquante sur l’absorption de la théophylline. Thérapie 41, 467–471 [PubMed] [Google Scholar]
  25. Bradwejn J., Zhou Y., Koszycki D., Shlik J. (2000). A double-blind, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects. J. Clin. Psychopharmacol. 20, 680. 10.1097/00004714-200012000-00015 [DOI] [PubMed] [Google Scholar]
  26. Cai Y., Luo Q., Sun M., Corke H. (2004). Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life Sci. 74, 2157–2184 10.1016/j.lfs.2003.09.047 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Chandel R. S., Kulshreshtha D. K., Rastogi R. P. (1977). Bacogenin-A3: a new sapogenin from Bacopa monniera. Phytochemistry 16, 141–143 10.1016/0031-9422(77)83039-2 [DOI] [Google Scholar]
  28. Chatterjee T. K., Chakraborty A., Pathak M., Sengupta G. C. (1992). Effects of plant extract Centella asiatica (Linn.) on cold restraint stress ulcer in rats. Indian J. Exp. Biol. 30, 889–891 [PubMed] [Google Scholar]
  29. Chen S. W., Wang W. J., Li W. J., Wang R., Li Y. L., Huang Y. N., Liang X. (2006). Anxiolytic-like effect of asiaticoside in mice. Pharmacol. Biochem. Behav. 85, 339–344 10.1016/j.pbb.2006.08.017 [DOI] [PubMed] [Google Scholar]
  30. Chopra R. N., Chopra I. C. (1958). Indigenous Drugs of India. Kolkata: Academic Publishers [Google Scholar]
  31. Chrubasik S., Droste C., Dragano N., Glimm E., Black A. (2006). Effectiveness and tolerability of the herbal mixture Asparagus P® on blood pressure in treatment-requiring antihypertensives. Phytomedicine 13, 740–742 10.1016/j.phymed.2006.01.009 [DOI] [PubMed] [Google Scholar]
  32. Curtis J. M., Grimsrud P. A., Wright W. S., Xu X., Foncea R. E., Graham D. W., Brestoff J. R., Wiczer B. M., Ilkayeva O., Cianflone K., Muoio D. E., Arriaga E. A., Bernlohr D. A. (2010). Downregulation of adipose glutathione S-transferase A4 leads to increased protein carbonylation, oxidative stress, and mitochondrial dysfunction. Diabetes 59, 1132–1142 10.2337/db09-1105 [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Dadkar V. N., Ranadive N. U., Dhar H. L. (1987). Evaluation of antistress (adaptogen) activity of Withania somnifera (ashwagandha). Indian J. Clin. Biochem. 2, 101–108 [Google Scholar]
  34. Dai D. F., Rabinovitch P. S., Ungvari Z. (2012). Mitochondria and cardiovascular aging. Circ. Res. 110, 1109–1124 10.1161/CIRCRESAHA.111.246140 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Dandiya P. C., Cullumbine H., Sellers E. A. (1959). Studies on Acorus calamus (IV): investigations on mechanism of action in mice. J. Pharmacol. Exp. Ther. 126, 334. [PubMed] [Google Scholar]
  36. Dandiya P. C., Menon M. K. (1963). Effects of asarone and β-asarone on conditioned responses, fighting behaviour and convulsions. Br. J. Pharmacol. Chemother. 20, 436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Dash B., Jounious A. M. M. (1997). Handbook of Ayurveda. New Delhi: Concept Publishing Company [Google Scholar]
  38. De Souza N. D., Shah V., Desai P. D., Inamdar P. K., Adolf D. SA., Ammonamanchi R., Dohadwalla A. N., Lakdawala A. D., Mandrekar S. S., Blumbach J. (1990). 2, 3, 23-Trihydroxy-urs-12-ene and its Derivatives, Processes for their Preparation and their Use. European Patent 383, A2 [Google Scholar]
  39. Deb D. D., Kapoor P., Dighe R. P., Padmaja R., Anand M. S., D’Souza P., Deepak M., Murali B., Agarwal A. (2008). In vitro safety evaluation and anticlastogenic effect of BacoMindTM on human lymphocytes. Biomed. Environ. Sci. 21, 7–23 10.1016/S0895-3988(08)60002-1 [DOI] [PubMed] [Google Scholar]
  40. Deshpande S. M., Srivastava D. N. (1969). Chemical studies of Convulvulus pluricaulis. J. Indian Chem. Soc. 46, 759–760 [Google Scholar]
  41. Deshpande S. M., Srivastava D. N. (1975). Gas chromatographic identification of fatty acids, fatty alcohols, and hydrocarbons of Convolvulus pluricaulis (Chois). J. Am. Oil Chem. Soc. 52, 318–319 10.1007/BF02637735 [DOI] [PubMed] [Google Scholar]
  42. Devasagayam T., Tilak J., Boloor K., Sane K., Ghaskadbi S., Lele R. (2004). Free radicals and antioxidants in human health: current status and future prospects. J. Assoc. Physicians India 52, 794–804 [PubMed] [Google Scholar]
  43. Devasagayam T. P. A., Boloor K. K., Ramasarma T. (2003). Methods for estimating lipid peroxidation: an analysis of merits and demerits. Indian J. Biochem. Biophys. 40, 300–308 [PubMed] [Google Scholar]
  44. Dhawan B. N., Singh H. K. (1996). Pharmacological studies on Bacopa monniera, an ayurvedic nootropic agent. Eur. Neuropsychopharmacol. 6, 144–144 10.1016/0924-977X(96)87967-3 [DOI] [Google Scholar]
  45. Dhuley J. N. (1998). Effect of ashwagandha on lipid peroxidation in stress-induced animals. J. Ethnopharmacol. 60, 173–178 10.1016/S0378-8741(97)00151-7 [DOI] [PubMed] [Google Scholar]
  46. Drummond G. R., Selemidis S., Griendling K. K., Sobey C. G. (2011). Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets. Nat. Rev. Drug Discov. 10, 453–471 10.1038/nrd3403 [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Durham S. E., Brown D. T., Turnbull D. M., Chinnery P. F. (2006). Progressive depletion of mtDNA in mitochondrial myopathy. Neurology 67, 502–504 10.1212/01.wnl.0000227961.55640.2f [DOI] [PubMed] [Google Scholar]
  48. Eastwood M. A. (1999). Interaction of dietary antioxidants in vivo: how fruit and vegetables prevent disease? QJM 92, 527–530 10.1093/qjmed/92.9.527 [DOI] [PubMed] [Google Scholar]
  49. Floyd R. A., Hensley K. (2002). Oxidative stress in brain aging. Implications for therapeutics of neurodegenerative diseases. Neurobiol. Aging 23, 795–807 10.1016/S0197-4580(02)00019-2 [DOI] [PubMed] [Google Scholar]
  50. Frawley D., Lad V. (2004). The Yoga of Herbs: An Ayurvedic Guide to Herbal Medicine. New Delhi: Motilal Banarsidass [Google Scholar]
  51. Gamlath C. B., Leslie Gunatilaka A. A., Tezuka Y., Kikuchi T., Balasubramaniam S. (1990). Quinone-methide, phenolic and related triterpenoids of plants of Celastraceae: further evidence for the structure of celastranhydride. Phytochemistry 29, 3189–3192 10.1016/0031-9422(90)80182-G [DOI] [Google Scholar]
  52. Garai S., Mahato S. B., Ohtani K., Yamasaki K. (1996). Dammarane-type triterpenoid saponins from Bacopa monniera. Phytochemistry 42, 815–820 10.1016/0031-9422(95)00936-1 [DOI] [PubMed] [Google Scholar]
  53. Gindi S. (2011). Evaluation of nootropic potential and in vitro antioxidant activity of aqueous extract of roots of Aparagus racemosus in rats. Int. J. Pharm. Res. Dev. 3, 184–191 [Google Scholar]
  54. Godkar P. B., Gordon R. K., Ravindran A., Doctor B. P. (2006). Celastrus paniculatus seed oil and organic extracts attenuate hydrogen peroxide- and glutamate-induced injury in embryonic rat forebrain neuronal cells. Phytomedicine 13, 29–36 10.1016/j.phymed.2003.11.011 [DOI] [PubMed] [Google Scholar]
  55. Govindarajan R., Vijayakumar M., Pushpangadan P. (2005). Antioxidant approach to disease management and the role of Rasayana’ herbs of Ayurveda. J. Ethnopharmacol. 99, 165–178 10.1016/j.jep.2005.02.035 [DOI] [PubMed] [Google Scholar]
  56. Gracanin M., Hawkins C. L., Pattison D. I., Davies M. J. (2009). Singlet-oxygen-mediated amino acid and protein oxidation: formation of tryptophan peroxides and decomposition products. Free Radic. Biol. Med. 47, 92–102 10.1016/j.freeradbiomed.2009.04.015 [DOI] [PubMed] [Google Scholar]
  57. Griffiths H. R., Lunec J. (1996). “Investigating the effects of oxygen free radicals on carbohydrates in biological systems,” in Free Radicals: a Practical Approach, eds Punchard N. A., Kelly F. J. (Oxford: Oxford University Press; ), 185–200 [Google Scholar]
  58. Gutteridge J. M. (1993). Free radicals in disease processes: a compilation of cause and consequence. Free Radic. Res. Commun. 19, 141. 10.3109/10715769309111598 [DOI] [PubMed] [Google Scholar]
  59. Halliwell B. (1994). Free radicals and antioxidants: a personal view. Nutr. Rev. 52, 253–265 10.1111/j.1753-4887.1994.tb01453.x [DOI] [PubMed] [Google Scholar]
  60. Halliwell B. (2001). Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18, 685–716 10.2165/00002512-200118090-00004 [DOI] [PubMed] [Google Scholar]
  61. Halliwell B. (2011). Free radicals and antioxidants-quo vadis? Trends Pharmacol. Sci. 32, 125–130 10.1016/j.tips.2010.12.002 [DOI] [PubMed] [Google Scholar]
  62. Hamid A. A., Shah Z. M., Muse R., Mohamed S. (2002). Characterisation of antioxidative activities of various extracts of Centella asiatica (L) urban. Food Chem. 77, 465–469 10.1016/S0308-8146(01)00384-3 [DOI] [Google Scholar]
  63. Harman D. (1956). Aging: a theory based on free radical and radiation chemistry. J. Gerontol. 11, 298–300 [DOI] [PubMed] [Google Scholar]
  64. Hayes P. Y., Jahidin A. H., Lehmann R., Penman K., Kitching W., De Voss J. J. (2008). Steroidal saponins from the roots of Asparagus racemosus. Phytochemistry 69, 796–804 10.1016/j.phytochem.2007.09.001 [DOI] [PubMed] [Google Scholar]
  65. Hertog H. J., Hackmann J. T., Nanavati D. D., Dev S. (1973). Malkanguniol, one of the polyalcohols from celastrus paniculatus Willd. Tetrahedron Lett. 14, 845–848 10.1016/S0040-4039(01)95732-6 [DOI] [Google Scholar]
  66. Hertog H. J., Kruk C., Nanavati D. D., Dev S. (1974). Stereochemistry of malkanguniol and stereostructures of some other related polyalcohols from celastrus paniculatus Willd. Tetrahedron Lett. 15, 2219–2222 [Google Scholar]
  67. Holcomb L. A., Dhanasekaran M., Hitt A. R., Young K. A., Riggs M., Manyam B. V. (2006). Bacopa monniera extract reduces amyloid levels in PSAPP mice. J. Alzheimers Dis. 9, 243–251 [DOI] [PubMed] [Google Scholar]
  68. Inamdar P. K., Yeole R. D., Ghogare A. B., De Souza N. J. (1996). Determination of biologically active constituents in Centella asiatica. J. Chromatogr. A 742, 127–130 10.1016/0021-9673(96)00237-3 [DOI] [Google Scholar]
  69. Irving G. R., Karmokar A., Berry D. P., Brown K., Steward W. P. (2011). Curcumin: the potential for efficacy in gastrointestinal diseases. Best Pract. Res. Clin. Gastroenterol. 25, 519–534 10.1016/j.bpg.2011.09.005 [DOI] [PubMed] [Google Scholar]
  70. Jain A. K., Tezuka H., Kada T., Tomita I. (1987). Evaluation of genotoxic effects of turmeric in mice. Curr. Sci. 56, 1005–1006 [Google Scholar]
  71. Jain M. K. (1963). Chemical examination of Celastrus paniculatus Willd. Indian J. Chem. 1, 500 [Google Scholar]
  72. James J. T., Dubery I. A. (2009). Pentacyclic triterpenoids from the medicinal herb, Centella asiatica (L.) urban. Molecules 14, 3922–3941 10.3390/molecules14103922 [DOI] [PMC free article] [PubMed] [Google Scholar]
  73. Jana U., Sur T. K., Maity L. N., Debnath P. K., Bhattacharyya D. (2010). A clinical study on the management of generalized anxiety disorder with Centella asiatica. Nepal Med. Coll. J. 12, 8–11 [PubMed] [Google Scholar]
  74. Jorge O. A., Jorge A. D. (2005). Hepatotoxicity associated with the ingestion of Centella asiatica. Rev. Esp. Enferm. Dig. 97, 115–124 10.4321/S1130-01082005000200006 [DOI] [PubMed] [Google Scholar]
  75. Joshi M. C., Sabnis S. D. (1989). A phytochemical study of South Gujarat forests plants with special reference to the medicinal and of ethnobotanical interest. Bull. Med. Ethnobot. Res. 10, 61–82 [Google Scholar]
  76. Jyoti A., Sharma D. (2006). Neuroprotective role of Bacopa monniera extract against aluminium-induced oxidative stress in the hippocampus of rat brain. Neurotoxicology 27, 451–457 10.1016/j.neuro.2005.12.007 [DOI] [PubMed] [Google Scholar]
  77. Kawai K. I., Shibata S. (1978). Pseudojujubogenin, a new sapogenin from Bacopa monniera. Phytochemistry 17, 287–289 10.1016/S0031-9422(00)94166-9 [DOI] [Google Scholar]
  78. Khare C. P. (2004). Indian Herbal Remedies: Rational Western Therapy, Ayurvedic, and other Traditional Usage, Botany. Berlin: Springer Publishing Company [Google Scholar]
  79. Kitazoe Y., Kishino H., Hasegawa M., Matsui A., Lane N., Tanaka M. (2011). Stability of mitochondrial membrane proteins in terrestrial vertebrates predicts aerobic capacity and longevity. Genome Biol. Evol. 3, 1233–1244 10.1093/gbe/evr079 [DOI] [PMC free article] [PubMed] [Google Scholar]
  80. Kiuchi F., Goto Y., Sugimoto N., Akao N., Kondo K., Tsuda Y. (1993). Nematocidal activity of turmeric: synergistic action of curcuminoids. Chem. Pharm. Bull. 41, 1640. 10.1248/cpb.41.1640 [DOI] [PubMed] [Google Scholar]
  81. Krebs N. F. (2001). Bioavailability of dietary supplements and impact of physiologic state: infants, children and adolescents. J. Nutr. 131, 1351S–1354S [DOI] [PubMed] [Google Scholar]
  82. Kulkarni S. K., Akula K. K., Dhir A. (2008). Effect of Withania somnifera Dunal root extract against pentylenetetrazol seizure threshold in mice: possible involvement of GABAergic system. Indian J. Exp. Biol. 46, 465–469 [PubMed] [Google Scholar]
  83. Kulshreshtha D. K., Rastogi R. P. (1973). Bacogenin-A1: a novel dammarane triterpene sapogenin from Bacopa monniera. Phytochemistry 12, 887–892 10.1016/S0031-9422(00)91552-8 [DOI] [Google Scholar]
  84. Kumar A., Prakash A., Dogra S. (2011). Centella asiatica attenuates D-galactose-induced cognitive impairment, oxidative and mitochondrial dysfunction in mice. Int. J. Alzheimers Dis. 2011, 347569. 10.1016/j.jalz.2011.05.1747 [DOI] [PMC free article] [PubMed] [Google Scholar]
  85. Kumar M. H., Gupta Y. K. (2002). Antioxidant property of Celastrus paniculatus Willd: a possible mechanism in enhancing cognition. Phytomedicine 9, 302–311 10.1078/0944-7113-00136 [DOI] [PubMed] [Google Scholar]
  86. Lander V., Schreier P. (1990). Acorenone and γ-asarone: indicators of the origin of calamus oils (Acorus calamus, L.). Flavour Fragr. J. 5, 75–79 [Google Scholar]
  87. Lapointe J., Hekimi S. (2010). When a theory of aging ages badly. Cell. Mol. Life Sci. 67, 1–8 10.1007/s00018-009-0138-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  88. Liao J. F., Huang S. Y., Jan Y. M., Yu L. L., Chen C. F. (1998). Central inhibitory effects of water extract of Acori graminei rhizoma in mice. J. Ethnopharmacol. 61, 185–193 10.1016/S0378-8741(98)00042-7 [DOI] [PubMed] [Google Scholar]
  89. Loiseau A., Mercier M. (2000). Centella asiatica and skin care. Cosmet. Toiletries 115, 63–67 [Google Scholar]
  90. Manikandan S., Srikumar R., Jeya Parthasarathy N., Devi R. S. (2005). Protective effect of Acorus calamus LINN on free radical scavengers and lipid peroxidation in discrete regions of brain against noise stress exposed rat. Biol. Pharm. Bull. 28, 2327–2330 10.1248/bpb.28.2327 [DOI] [PubMed] [Google Scholar]
  91. Matsuda H., Morikawa T., Ueda H., Yoshikawa M. (2001). Medicinal foodstuffs. XXVII. Saponin constituents of gotu kola (2): structures of new ursane-and oleanane-type triterpene oligoglycosides, centellasaponins B, C, and D, from Centella asiatica cultivated in Sri Lanka. Chem. Pharm. Bull. 49, 1368–1371 10.1248/cpb.49.69 [DOI] [PubMed] [Google Scholar]
  92. Mehta A. K., Binkley P., Gandhi S. S., Ticku M. K. (1991). Pharmacological effects of Withania somnifera root extract on GABAA receptor complex. Indian J. Med. Res. 94, 312–315 [PubMed] [Google Scholar]
  93. Mook-Jung I., Shin J. E., Yun S. H., Huh K., Koh J. Y., Park H. K., Jew S. S., Jung M. W. (1999). Protective effects of asiaticoside derivatives against beta-amyloid neurotoxicity. J. Neurosci. Res. 58, 417–425 10.1002/(SICI)1097-4547(19991101)58:3<417::AID-JNR7>3.3.CO;2-7 [DOI] [PubMed] [Google Scholar]
  94. Morris J. V., MacGillivray R. C., Mathieson C. M. (1953). Celastrus paniculata in mental deficiency: a pilot experiment. Br. J. Psychiatry 99, 158–160 10.1192/bjp.99.414.158 [DOI] [PubMed] [Google Scholar]
  95. Muellenbach E. A., Diehl C. J., Teachey M. K., Lindborg K. A., Archuleta T. L., Harrell N. B., Andersen G., Somoza V., Hasselwander O., Matuschek M., Henriksen E. J. (2008). Interactions of the advanced glycation end product inhibitor pyridoxamine and the antioxidant alpha-lipoic acid on insulin resistance in the obese Zucker rat. Metab. Clin. Exp. 57, 1465–1472 10.1016/j.metabol.2008.05.018 [DOI] [PMC free article] [PubMed] [Google Scholar]
  96. Muellenbach E. M., Diehl C. J., Teachey M. K., Lindborg K. A., Hasselwander O., Matuschek M., Henriksen E. J. (2009). Metabolic interactions of AGE inhibitor pyridoxamine and antioxidant alpha-lipoic acid following 22 weeks of treatment in obese Zucker rats. Life Sci. 84, 563–568 10.1016/j.lfs.2009.01.021 [DOI] [PMC free article] [PubMed] [Google Scholar]
  97. Mustapha A., Yakasai I. A., Abdu Aguye I. (1996). Effect of Tamarindus indica L. on the bioavailability of aspirin in healthy human volunteers. Eur. J. Drug Metab. Pharmacokinet. 21, 223–226 10.1007/BF03189717 [DOI] [PubMed] [Google Scholar]
  98. Mythri R. B., Bharath M. M. (2012). Curcumin: a potential neuroprotective agent in Parkinson’s disease. Curr. Pharm. Des. 18, 91–99 10.2174/138161212798918995 [DOI] [PubMed] [Google Scholar]
  99. Nadkarni K. M. (1910). Indian Plants and Drugs with their Medical Properties and Uses. Chennai: Norton & Co. [Google Scholar]
  100. Nag G., De B. (2008). Antioxidant and acetylcholinesterase inhibitory properties of the Indian medicinal plant “Shankhapushpi” used for enhancing memory function. J. Complement. Integr. Med. 5, 26 [Google Scholar]
  101. Nakayama R., Tamura Y., Yamanaka H., Kikuzaki H., Nakatani N. (1993). Two curcuminoid pigments from Curcuma domestica. Phytochemistry 33, 501–502 10.1016/0031-9422(93)85548-6 [DOI] [Google Scholar]
  102. Ojha R., Sahu A. N., Muruganandam A. V., Singh G. K., Krishnamurthy S. (2010). Asparagus recemosus enhances memory and protects against amnesia in rodent models. Brain Cogn. 74, 1–9 10.1016/j.bandc.2010.05.009 [DOI] [PubMed] [Google Scholar]
  103. Pajno G. B., Passalacqua G., La Grutta S., Vita D., Feliciotto R., Parmiani S., Barberio G. (2002). True multifood allergy in a 4-year-old child: a case study. Allergol. Immunopathol. (Madr) 30, 338–341 [DOI] [PubMed] [Google Scholar]
  104. Panda S., Kar A. (1997). Evidence for free radical scavenging activity of ashwagandha root powder in mice. Indian J. Physiol. Pharmacol. 41, 424. [PubMed] [Google Scholar]
  105. Parihar M. S., Hemnani T. (2003). Phenolic antioxidants attenuate hippocampal neuronal cell damage against kainic acid induced excitotoxicity. J. Biosci. 28, 121–128 10.1007/BF02970142 [DOI] [PubMed] [Google Scholar]
  106. Parihar M. S., Hemnani T. (2004). Experimental excitotoxicity provokes oxidative damage in mice brain and attenuation by extract of Asparagus racemosus. J. Neural Transm. 111, 1–12 10.1007/s00702-003-0069-8 [DOI] [PubMed] [Google Scholar]
  107. Park S. Y., Kim D. S. (2002). Discovery of natural products from Curcuma longa that protect cells from beta-amyloid insult: a drug discovery effort against Alzheimer’s disease. J. Nat. Prod. 65, 1227–1231 10.1021/np010039x [DOI] [PubMed] [Google Scholar]
  108. Patel V., Rink C., Khanna S., Sen C. K. (2011). Tocotrienols: the lesser known form of natural vitamin E. Indian J. Exp. Biol. 49, 732–738 [PMC free article] [PubMed] [Google Scholar]
  109. Perry G., Nunomura A., Hirai K., Zhu X., Perez M., Avila J., Castellani R. J., Atwood C. S., Aliev G., Sayre L. M., Takeda A., Smith M. A. (2002). Is oxidative damage the fundamental pathogenic mechanism of Alzheimer’s and other neurodegenerative diseases? Free Radic. Biol. Med. 33, 1475–1479 10.1016/S0891-5849(02)01113-9 [DOI] [PubMed] [Google Scholar]
  110. Pittella F., Dutra R. C., Junior D. D., Lopes M. T., Barbosa N. R. (2009). Antioxidant and cytotoxic activities of Centella asiatica (L) urban. Int. J. Mol. Sci. 10, 3713–3721 10.3390/ijms10093713 [DOI] [PMC free article] [PubMed] [Google Scholar]
  111. Poljsak B. (2011). Strategies for reducing or preventing the generation of oxidative stress. Oxid. Med. Cell. Longev. 2011, 194586. 10.1155/2011/760978 [DOI] [PMC free article] [PubMed] [Google Scholar]
  112. Ponnusamy K., Mohan M., Nagaraja H. S. (2008). Protective antioxidant effect of Centella asiatica bioflavonoids on lead acetate induced neurotoxicity. Med. J. Malaysia 63, 102. [PubMed] [Google Scholar]
  113. Pravina K., Ravindra K. R., Goudar K. S., Vinod D. R., Joshua A. J., Wasim P., Venkateshwarlu K., Saxena V. S., Amit A. (2007). Safety evaluation of BacoMind− in healthy volunteers: a phase I study. Phytomedicine 14, 301–308 10.1016/j.phymed.2007.03.010 [DOI] [PubMed] [Google Scholar]
  114. Procházková D., Boušová I., Wilhelmová N. (2011). Antioxidant and prooxidant properties of flavonoids. Fitoterapia 82, 513–523 10.1016/j.fitote.2011.01.018 [DOI] [PubMed] [Google Scholar]
  115. Qin L. P., Ding R. X., Zhang W. D. (1998). Essential oil from Centella asiatica and its antidepressant activity. Di Er Jun Yi Da Xue Xue Bao 19, 186–187 [Google Scholar]
  116. Radi R., Peluffo G., Alvarez M. N., Naviliat M., Cayota A. (2001). Unraveling peroxynitrite formation in biological systems. Free Radic. Biol. Med. 30, 463–488 10.1016/S0891-5849(00)00373-7 [DOI] [PubMed] [Google Scholar]
  117. Raha S., Robinson B. H. (2000). Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem. Sci. 25, 502–508 10.1016/S0968-0004(00)01674-1 [DOI] [PubMed] [Google Scholar]
  118. Rai D., Bhatia G., Palit G., Pal R., Singh S., Singh H. K. (2003). Adaptogenic effect of Bacopa monniera(Brahmi). Pharmacol. Biochem. Behav. 75, 823–830 10.1016/S0091-3057(03)00156-4 [DOI] [PubMed] [Google Scholar]
  119. Raina V. K., Srivastava S. K., Syamasunder K. V. (2003). Essential oil composition of Acorus calamus L. from the lower region of the Himalayas. Flavour Fragr. J. 18, 18–20 10.1002/ffj.1222 [DOI] [Google Scholar]
  120. Rajakrishnan V., Viswanathan P., Rajasekharan K. N., Menon V. P. (1999). Neuroprotective role of curcumin from curcuma longa on ethanol-induced brain damage. Phytother. Res. 13, 571–574 10.1002/(SICI)1099-1573(199911)13:7<571::AID-PTR494>3.3.CO;2-Z [DOI] [PubMed] [Google Scholar]
  121. Ramanathan M., Sivakumar S., Anandvijayakumar P. R., Saravanababu C., Pandian P. R. (2007). Neuroprotective evaluation of standardized extract of Centella asciatica in monosodium glutamate treated rats. Indian J. Exp. Biol. 45, 425–431 [PubMed] [Google Scholar]
  122. Ramanathan M., Srinivasan J., Saravanababu C., Viswanad B., Suresh B. (2003). Comparative behavioral activity of methanolic and aqueous Withania somnifera root extracts in stressed rats. Indian J. Pharm. Sci. 65, 601–604 [Google Scholar]
  123. Ramaswamy A. S., Periyasamy S. M., Basu N. (1970). Pharmacological studies on Centella asaitica Linn.(Brahma manduki)(no Umbelliferae). J. Res. Indian. Med. 4, 160–175 [Google Scholar]
  124. Rao A. S. K., Rao K. (1973). Effect of Mandookaparni (Centella asiatica) on the general mental ability (Medhya) of mentally retarded children. Indian J. Med. Res. 8, 9–16 [Google Scholar]
  125. Rao K. G. M., Rao S. M., Rao S. G. (2006). Centella asiatica (L.) leaf extract treatment during the growth spurt period enhances hippocampal CA3 neuronal dendritic arborization in rats. Evid. Based Complement. Alternat. Med. 3, 349–357 10.1093/ecam/nel024 [DOI] [PMC free article] [PubMed] [Google Scholar]
  126. Rao K. G. M., Rao S. M., Rao S. G. (2009). Enhancement of amygdaloid neuronal dendritic arborization by fresh leaf juice of Centella asiatica (Linn) during growth spurt period in rats. Evid. Based Complement. Alternat. Med. 6, 203–210 10.1093/ecam/nem079 [DOI] [PMC free article] [PubMed] [Google Scholar]
  127. Rao M. N. A. (1994). Curcuminoids as potent inhibitors of lipid peroxidation. J. Pharm. Pharmacol. 46, 1013–1016 [DOI] [PubMed] [Google Scholar]
  128. Rao S. B., Chetana M., Uma Devi P. (2005). Centella asiatica treatment during postnatal period enhances learning and memory in mice. Physiol. Behav. 86, 449–457 10.1016/j.physbeh.2005.07.019 [DOI] [PubMed] [Google Scholar]
  129. Rastogi L., Patnaik G. K., Dikshit M. (1998). Free radicals and antioxidant status following pylorus ligation induced gastric mucosal injury in rats. Pharmacol. Res. 38, 125–132 10.1006/phrs.1998.0343 [DOI] [PubMed] [Google Scholar]
  130. Rastogi R. P., Mehrotra B. N. (1990). Compendium of Indian Medicinal Plants. Lucknow: Central Drug Research Institute [Google Scholar]
  131. Rastogi S. (2010). Building bridges between ayurveda and modern science. Int. J. Ayurveda Res. 1, 41. 10.4103/0974-7788.64398 [DOI] [PMC free article] [PubMed] [Google Scholar]
  132. Ravindranath V., Satyanarayana M. N. (1980). An unsymmetrical diarylheptanoid from Curcuma longa. Phytochemistry 19, 2031–2032 10.1016/0031-9422(80)83033-0 [DOI] [Google Scholar]
  133. Reddy V. C., Vidya Sagar G. V., Sreeramulu D., Venu L., Raghunath M. (2005). Addition of milk does not alter the antioxidant activity of black tea. Ann. Nutr. Metab. 49, 189–195 10.1159/000087071 [DOI] [PubMed] [Google Scholar]
  134. Rieker J., Ruzicka T., Neumann N. J., Bielicky P., Homey B. (2004). Type I and type IV sensitization to Asparagus officinalis. Hautarzt 55, 397. 10.1007/s00105-004-0717-4 [DOI] [PubMed] [Google Scholar]
  135. Rohini G., Sabitha K. E., Devi C. S. (2004). Bacopa monniera Linn. extract modulates antioxidant and marker enzyme status in fibrosarcoma bearing rats. Indian J. Exp. Biol. 42, 776. [PubMed] [Google Scholar]
  136. Roth G. N., Chandra A., Nair M. G. (1998). Novel bioactivities of Curcuma longa constituents. J. Nat. Prod. 61, 542–545 10.1021/np970459f [DOI] [PubMed] [Google Scholar]
  137. Ryan M. J., Dudash H. J., Docherty M., Geronilla K. B., Baker B. A., Haff G. G., Cutlip R. G., Alway S. E. (2010). Vitamin E and C supplementation reduces oxidative stress, improves antioxidant enzymes and positive muscle work in chronically loaded muscles of aged rats. Exp. Gerontol. 45, 882–895 10.1016/j.exger.2010.08.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
  138. Sandeep D., Nair C. K. K. (2010). Protection of DNA and membrane from γ-radiation induced damage by the extract of Acorus calamus Linn.: an in vitro study. Environ. Toxicol. Pharmacol.. 29, 302–307 10.1016/j.etap.2010.02.006 [DOI] [PubMed] [Google Scholar]
  139. Sastre J., Pallardó F. V., García de la Asunción J., Viña J. (2000). Mitochondria, oxidative stress and aging. Free Radic. Res. 32, 189–198 10.1080/10715760000300201 [DOI] [PubMed] [Google Scholar]
  140. Schaffer M., Schaffer P. M., Zidan J., Bar Sela G. (2011). Curcuma as a functional food in the control of cancer and inflammation. Curr. Opin. Clin. Nutr. Metab. Care 14, 588–597 10.1097/MCO.0b013e32834bfe94 [DOI] [PubMed] [Google Scholar]
  141. Sethiya N. K., Mishra S. H. (2010). Review on ethanomedicinal uses and phyto-pharmacology of memory boosting herb Convolvulus pluricaulis Choisy. Aus. J. Med. Herb. 22, 19–25 [Google Scholar]
  142. Shah C. S., Qadry J. S. (1990). A Text Book of Pharmacognosy. BS Prakashan [Google Scholar]
  143. Shahidi F. (1997). Natural Antioxidants: Chemistry, Health Effects, and Applications. Urbana Champaign: Amer Oil Chemists Society Press [Google Scholar]
  144. Shinomol G. K. Muralidhara (2008). Prophylactic neuroprotective property of Centella asiatica against 3-nitropropionic acid induced oxidative stress and mitochondrial dysfunctions in brain regions of prepubertal mice. Neurotoxicology 29, 948–957 10.1016/j.neuro.2008.09.009 [DOI] [PubMed] [Google Scholar]
  145. Shinomol G. K., Ravikumar H., Muralidhara (2010). Prophylaxis with Centella asiatica confers protection to prepubertal mice against 3-nitropropionic-acid-induced oxidative stress in brain. Phytother. Res. 24, 885–892 [DOI] [PubMed] [Google Scholar]
  146. Shukla A., Rasik A. M., Jain G. K., Shankar R., Kulshrestha D. K., Dhawan B. N. (1999). In vitro and in vivo wound healing activity of asiaticoside isolated from Centella asiatica. J. Ethnopharmacol. 65, 1–11 10.1016/S0378-8741(98)00141-X [DOI] [PubMed] [Google Scholar]
  147. Shukla P. K., Khanna V. K., Ali M. M., Maurya R. R., Handa S. S., Srimal R. C. (2002). Protective effect of acorus calamus against acrylamide induced neurotoxicity. Phytother. Res. 16, 256–260 10.1002/ptr.854 [DOI] [PubMed] [Google Scholar]
  148. Singh G., Singh O. P., Maurya S. (2002). Chemical and biocidal investigations on essential oils of some Indian Curcuma species. Prog. Cryst. Growth Character. Mat. 45, 75–81 10.1016/S0960-8974(02)00030-X [DOI] [Google Scholar]
  149. Singh G. K., Bhandari A. (2000). Text Book of Pharmacognosy. New Delhi: CBS Publishers, 193–194 [Google Scholar]
  150. Singh R. H., Narsimhamurthy K., Singh G. (2008). Neuronutrient impact of Ayurvedic Rasayana therapy in brain aging. Biogerontology 9, 369–374 10.1007/s10522-008-9124-z [DOI] [PubMed] [Google Scholar]
  151. Siow R. C., Mann G. E. (2010). Dietary isoflavones and vascular protection: activation of cellular antioxidant defenses by SERMs or hormesis? Mol. Aspects Med. 31, 468–477 10.1016/j.mam.2010.09.003 [DOI] [PubMed] [Google Scholar]
  152. Sivalokanathan S., Ilayaraja M., Balasubramanian M. P. (2006). Antioxidant activity of Terminalia arjuna bark extract on N-nitrosodiethylamine induced hepatocellular carcinoma in rats. Mol. Cell. Biochem. 281, 87–93 10.1007/s11010-006-0433-8 [DOI] [PubMed] [Google Scholar]
  153. Smith M. A., Petot G. J., Perry G. (1999). Diet and oxidative stress: a novel synthesis of epidemiological data on Alzheimer’s disease. J. Alzheimers Dis. 1, 203–206 [DOI] [PubMed] [Google Scholar]
  154. Stadtman E. R. (1992). Protein oxidation and aging. Science 257, 1220–1224 10.1126/science.1355616 [DOI] [PubMed] [Google Scholar]
  155. Stohs S. J. (1995). The role of free radicals in toxicity and disease. J. Basic. Clin. Physiol. Pharmacol. 6, 205–228 10.1515/JBCPP.1995.6.3-4.205 [DOI] [PubMed] [Google Scholar]
  156. Styskal J., Van Remmen H., Richardson A., Salmon A. B. (2012). Oxidative stress and diabetes: what can we learn about insulin resistance from antioxidant mutant mouse models? Free Radic. Biol. Med. 52, 46–58 10.1016/j.freeradbiomed.2011.10.441 [DOI] [PMC free article] [PubMed] [Google Scholar]
  157. Sudarshan S. R. (2005). Encyclopaedia of Indian Medicine: Materia Medica-Herbal Drugs. Bangalore: Popular Prakashan [Google Scholar]
  158. Sun A. Y., Simonyi A., Sun G. Y. (2002). The “French Paradox” and beyond: neuroprotective effects of polyphenols. Free Radic. Biol. Med. 32, 314–318 10.1016/S0891-5849(01)00803-6 [DOI] [PubMed] [Google Scholar]
  159. Tabar A. I., Alvarez-Puebla M. J., Gomez B., Sanchez-Monge R., Garcia B. E., Echechipia S., Olaguibel J. M., Salcedo G. (2004). Diversity of asparagus allergy: clinical and immunological features. Clin. Exp. Allergy 34, 131–136 10.1111/j.1365-2222.2004.01856.x [DOI] [PubMed] [Google Scholar]
  160. Tee E. S., Ismail M. N., Nasir M. A., Khatijah I. (1997). “Nutrient composition of Malaysian foods,” in Malaysian Food Composition Database Programme. Kuala Lumpur: Institute for Medical Research [Google Scholar]
  161. Thakur R. S., Puri H. S., Husain A. (1989). Major Medicinal Plants of India. Lucknow: Central Institute of Medicinal and Aromatic Plants, 585 [Google Scholar]
  162. Tilak J. C., Devasagayam T. P. A., Adhikari S., Lele R. D., Kon T., Handa O., Naito Y., Yoshikawa T. (2006). Cellular membrane protection against reactive oxygen species by Terminalia arjuna and its active component Baicalein. J. Clin. Biochem. Nutr. 39, 75–87 10.3164/jcbn.39.75 [DOI] [Google Scholar]
  163. Tripathi Y. B., Chaurasia S., Tripathi E., Upadhyay A., Dubey G. P. (1996). Bacopa monniera Linn. as an antioxidant: mechanism of action. Indian J. Exp. Biol. 34, 523. [PubMed] [Google Scholar]
  164. Tsao R., Akhtar M. H. (2005). Nutraceuticals and functional foods. 1: current trend in phytochemical antioxidant research. J. Food Agric. Environ. 3, 10–17 [Google Scholar]
  165. Valko M., Izakovic M., Mazur M., Rhodes C. J., Telser J. (2004). Role of oxygen radicals in DNA damage and cancer incidence. Mol. Cell. Biochem. 266, 37–56 10.1023/B:MCBI.0000049134.69131.89 [DOI] [PubMed] [Google Scholar]
  166. Valko M., Leibfritz D., Moncol J., Cronin M. T., Mazur M., Telser J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int. J. Biochem. Cell Biol. 39, 44–84 10.1016/j.biocel.2006.07.001 [DOI] [PubMed] [Google Scholar]
  167. Valko M., Rhodes C. J., Moncol J., Izakovic M., Mazur M. (2006). Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem. Biol. Interact. 160, 1–40 10.1016/j.cbi.2005.12.009 [DOI] [PubMed] [Google Scholar]
  168. Vijayan V., Helen A. (2007). Protective activity of Bacopa monniera Linn. on nicotine-induced toxicity in mice. Phytother. Res. 21, 378–381 10.1002/ptr.2073 [DOI] [PubMed] [Google Scholar]
  169. Vimal S., Sissodia S. S., Meena P., Barber S., Shukla S., Saxena A., Patro N., Patro I., Bhatnagar M. (2010). Antioxidant effects of asparagus racemosus wild and Withania somnifera dunal in rat brain. Ann. Neurosci. 12, 67–70 10.5214/ans.0972.7531.2005.120401 [DOI] [Google Scholar]
  170. Vimala S., Adenan M. I., Ahmad A. R., Shahdan R. (2003). Nature’s Choice to Wellness: Antioxidant Vegetables/Ulam. Kuala Lumpur: Forest Research Institute Malaysia [Google Scholar]
  171. Vohora S. B., Shah S. A., Dandiya P. C. (1990). Central nervous system studies on an ethanol extract of Acorus calamus rhizomes. J. Ethnopharmacol. 28, 53–62 10.1016/0378-8741(90)90065-2 [DOI] [PubMed] [Google Scholar]
  172. Volz T., Berner D., Weigert C., Röcken M., Biedermann T. (2005). Fixed food eruption caused by asparagus. J. Allergy Clin. Immunol. 116, 1390–1392 10.1016/j.jaci.2005.09.032 [DOI] [PubMed] [Google Scholar]
  173. Wallace T. C. (2011). Anthocyanins in cardiovascular disease. Adv. Nutr. 2, 1–7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  174. Warrier P. K., Nambiar V. P. K., Ramankutty C. (1996). Indian Medicinal Plants: A Compendium of 500 Species. Hyderabad: Orient Blackswan [Google Scholar]
  175. Williamson E. M. (2002). Major Herbs of Ayurveda London: Elsevier Health Sciences [Google Scholar]
  176. Williamson G., Manach C. (2005). Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am. J. Clin. Nutr. 81, 243S–255S [DOI] [PubMed] [Google Scholar]
  177. Youdim K. A., Shukitt-Hale B., Joseph J. A. (2004). Flavonoids and the brain: interactions at the blood–brain barrier and their physiological effects on the central nervous system. Free Radic. Biol. Med. 37, 1683–1693 10.1016/j.freeradbiomed.2004.08.002 [DOI] [PubMed] [Google Scholar]
  178. Zanoli P., Avallone R., Baraldi M. (1998). Sedative and hypothermic effects induced by β-asarone, a main component of Acorus calamus. Phytother. Res. 12, S114–S116 10.1002/(SICI)1099-1573(199803)12:2<114::AID-PTR206>3.0.CO;2-8 [DOI] [Google Scholar]
  179. Zheng C. J., Qin L. P. (2007). Chemical components of Centella asiatica and their bioactivities. Zhong Xi Yi Jie He Xue Bao 5, 348. 10.3736/jcim20070324 [DOI] [PubMed] [Google Scholar]

Articles from Frontiers in Neuroscience are provided here courtesy of Frontiers Media SA

RESOURCES